Skip to main content
Premium Trial:

Request an Annual Quote

Analyst: Illumina's Takeover Clock Ticking

One year. That's how long Illumina CEO Jay Flatley has to prove he can increase his company's value beyond Roche's $6.7 billion takeover bid, Maxim Group analyst Bryan Brokmeier tells Bloomberg.

As our sister publication GenomeWeb Daily News reports, Roche this week said it would not extend its $51-per-share cash tender offer, ending its bid for the firm for now. GWDN adds that Illumina's shareholders this week voted on four Illumina board member slots "as well as a move by Roche to amend Illumina's bylaws in order to expand the San Diego company's board." Illumina said its shareholders re-elected board members including Flatley, Chairman William Rastetter, Blaine Bowman, and Karin Eastham.

Maxim Group's Brokmeier tells Bloomberg that to make it tougher for Roche to gain control of his firm's board at its 2013 shareholder meeting, Flatley "must introduce new products, either in-house or through acquisitions, and expand sales to get the shares rising."

Brokmeier goes on to add that Roche's recent move — to let its tender offer expire — does not signal the end of its bid. "They may come back with an offer if Illumina shares don't move higher and shareholders see they shouldn't have walked. Or if Illumina comes out with better news on its pipeline and greater information," he tells Bloomberg.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.